The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice ; day:30 ; month:9 ; year:2024 ; pages:1-21
Psychopharmacology ; (30.9.2024), 1-21

Creator
Wingfield, Kelly K.
Misic, Teodora
Jain, Kaahini
McDermott, Carly S.
Abney, Nalia M.
Richardson, Kayla T.
Rubman, Mia B.
Beierle, Jacob A.
Miracle, Sophia A.
Sandago, Emma J.
Baskin, Britahny M.
Lynch, William B.
Borrelli, Kristyn N.
Yao, Emily J.
Wachman, Elisha M.
Bryant, Camron D.
Contributor
SpringerLink (Online service)

DOI
10.1007/s00213-024-06694-7
URN
urn:nbn:de:101:1-2412152112296.599686990817
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Wingfield, Kelly K.
  • Misic, Teodora
  • Jain, Kaahini
  • McDermott, Carly S.
  • Abney, Nalia M.
  • Richardson, Kayla T.
  • Rubman, Mia B.
  • Beierle, Jacob A.
  • Miracle, Sophia A.
  • Sandago, Emma J.
  • Baskin, Britahny M.
  • Lynch, William B.
  • Borrelli, Kristyn N.
  • Yao, Emily J.
  • Wachman, Elisha M.
  • Bryant, Camron D.
  • SpringerLink (Online service)

Other Objects (12)

Pharmacological profiles of opioid ligands at Kappa opioid receptors

Pharmacological profiles of opioid ligands at Kappa opioid receptors

Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)

Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome

Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome

Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome

Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study

Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study

Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome

Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome

The Role of Lofexidine in Management of Opioid Withdrawal

The Role of Lofexidine in Management of Opioid Withdrawal

Single high-dose buprenorphine for opioid craving during withdrawal

Single high-dose buprenorphine for opioid craving during withdrawal

Atypical presentation of opioid withdrawal, an effect of adulteration

Atypical presentation of opioid withdrawal, an effect of adulteration

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)

Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation

Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation

Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study

Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study

Related objects